Nutex Health Inc. (NASDAQ:NUTX – Get Free Report)’s stock price rose 1% on Thursday . The company traded as high as $35.49 and last traded at $33.67. Approximately 68,164 shares changed hands during mid-day trading, an increase of 58% from the average daily volume of 43,148 shares. The stock had previously closed at $33.33.
Analysts Set New Price Targets
A number of equities analysts have issued reports on the company. Benchmark upped their target price on Nutex Health from $45.00 to $60.00 and gave the company a “buy” rating in a research report on Tuesday, November 12th. Maxim Group increased their price objective on shares of Nutex Health from $45.00 to $50.00 and gave the company a “buy” rating in a research note on Tuesday, November 12th.
Check Out Our Latest Research Report on NUTX
Nutex Health Trading Up 3.9 %
Institutional Investors Weigh In On Nutex Health
Several hedge funds and other institutional investors have recently bought and sold shares of NUTX. Beaird Harris Wealth Management LLC purchased a new position in Nutex Health in the 3rd quarter worth about $69,000. International Assets Investment Management LLC acquired a new position in Nutex Health in the 3rd quarter worth approximately $188,000. State Street Corp purchased a new position in Nutex Health during the 3rd quarter worth approximately $225,000. Thompson Davis & CO. Inc. acquired a new stake in Nutex Health during the 3rd quarter valued at $494,000. Finally, Essex Investment Management Co. LLC purchased a new stake in shares of Nutex Health in the third quarter valued at $1,579,000. 5.32% of the stock is currently owned by institutional investors.
Nutex Health Company Profile
Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.
Featured Articles
- Five stocks we like better than Nutex Health
- 2 Rising CRM Platform Stocks That Can Surge Higher in 2025
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- Buy P&G Now, Before It Sets A New All-Time High
- Texas Instruments: The Old-School Tech Titan Still Delivering
- Do ETFs Pay Dividends? What You Need to Know
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Receive News & Ratings for Nutex Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutex Health and related companies with MarketBeat.com's FREE daily email newsletter.